Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€3.73
25.04.24
-
25.04.25
2.28%
07:24

Risky Investment
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
25.04.24
-
25.04.25
-1.53%
07:24

Could be worthwhile Investment >10% per year
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€2.68
24.04.24
-
24.04.25
2.01%
26.04.24

Could be worthwhile Investment >10% per year
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.49
23.04.24
€3.00
23.04.25
-9.36%
01:00

Good rating
Growths much faster than the competition
Leading role in innovation
Very good company culture
B2gold Corp.

Start price
Target price
Perf. (%)
€2.74
15.04.24
-
15.04.25
-14.17%
25.04.24

Could be very worthwhile Investment >20% year
Below average Marketposition
Very high cyclical dependencies
Unknown brand
buy
Entera Bio

Start price
Target price
Perf. (%)
€2.32
13.04.24
-
13.04.25
-19.83%
01:00

Could be worthwhile Investment >10% per year
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-6.54%
01:00

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
Inotiv Inc.

Start price
Target price
Perf. (%)
€5.50
13.04.24
€4.00
13.04.25
-31.27%
01:00

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€22.07
13.04.24
€2.00
13.04.25
-5.48%
01:00

Probably not worthwhile Investment
EBIT decline/stagnation expected
negative Cash Flow expected
Bad rating
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
13.04.24
€2.00
13.04.25
-9.27%
01:00

negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
buy
Aperam S.A.

Start price
Target price
Perf. (%)
€29.36
13.04.24
-
13.04.25
-4.84%
01:00

buy
Aperam S.A.

Start price
Target price
Perf. (%)
€29.36
13.04.24
-
13.04.25
-4.84%
01:00

buy
Snap-On Inc.

Start price
Target price
Perf. (%)
€271.90
12.04.24
-
12.04.25
0.11%
13.04.24

buy
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.72
11.04.24
-
11.04.25
-12.21%
14.04.24

Could be worthwhile Investment >10% per year
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.50
11.04.24
-
11.04.25
3.27%
14.04.24

Risky Investment
buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€484.15
11.04.24
-
11.04.25
-1.43%
13.04.24

buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€484.15
11.04.24
-
11.04.25
-1.43%
13.04.24

buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€484.15
11.04.24
-
11.04.25
-1.43%
13.04.24

buy
Aperam S.A.

Start price
Target price
Perf. (%)
€29.90
11.04.24
-
11.04.25
-1.81%
13.04.24

buy
Aperam S.A.

Start price
Target price
Perf. (%)
€29.90
11.04.24
-
11.04.25
-1.81%
13.04.24

buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.91
08.04.24
€3.00
08.04.25
-22.47%
08:33

Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€66.50
07.04.24
-
07.04.25
0.75%
14.04.24

Could be very worthwhile Investment >20% year
buy
Advanced Micro Devices Inc.

Start price
Target price
Perf. (%)
€163.46
04.04.24
€165.00
04.04.25
-10.02%
08:34

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
buy
Advanced Micro Devices Inc.

Start price
Target price
Perf. (%)
€163.46
04.04.24
€165.00
04.04.25
-10.02%
08:34

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
buy
Advanced Micro Devices Inc.

Start price
Target price
Perf. (%)
€163.46
04.04.24
€165.00
04.04.25
-10.02%
08:34

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model